Jay Lakshman

489 total citations
6 papers, 336 citations indexed

About

Jay Lakshman is a scholar working on Pharmaceutical Science, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jay Lakshman has authored 6 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmaceutical Science, 3 papers in Molecular Biology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jay Lakshman's work include Drug Solubulity and Delivery Systems (4 papers), Protein purification and stability (3 papers) and Analytical Methods in Pharmaceuticals (2 papers). Jay Lakshman is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Protein purification and stability (3 papers) and Analytical Methods in Pharmaceuticals (2 papers). Jay Lakshman collaborates with scholars based in United States and Switzerland. Jay Lakshman's co-authors include Abu T.M. Serajuddin, Yu Cao, Wei‐Qin Tong, Madhav Vasanthavada, Yatindra M. Joshi, Thomas Haefele, Manisha Mone, Yanfeng Wang, Rosario LoBrutto and Changkang Pan and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Molecular Pharmaceutics and ACS Infectious Diseases.

In The Last Decade

Jay Lakshman

6 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jay Lakshman United States	5	281	117	96	47	43	6	336
Maxim Puchkov Switzerland	9	308 1.1×	120 1.0×	72 0.8×	36 0.8×	39 0.9×	12	451
Madhav Vasanthavada United States	6	388 1.4×	208 1.8×	99 1.0×	83 1.8×	63 1.5×	7	458
Hiroyasu Kokubo Japan	11	252 0.9×	56 0.5×	69 0.7×	45 1.0×	59 1.4×	18	395
Johanna Laru Finland	6	378 1.3×	124 1.1×	98 1.0×	33 0.7×	25 0.6×	6	503
L. Dierickx Belgium	7	219 0.8×	103 0.9×	99 1.0×	99 2.1×	38 0.9×	9	356
Wantanee Phuapradit United States	10	262 0.9×	76 0.6×	68 0.7×	54 1.1×	29 0.7×	14	353
Tze Ning Hiew United States	11	250 0.9×	142 1.2×	58 0.6×	53 1.1×	41 1.0×	19	335
Susanne Page Switzerland	11	206 0.7×	98 0.8×	66 0.7×	41 0.9×	36 0.8×	20	316
Mark T. Davis Ireland	8	294 1.0×	123 1.1×	67 0.7×	43 0.9×	96 2.2×	8	409
Sandra Guns Belgium	5	410 1.5×	152 1.3×	97 1.0×	71 1.5×	154 3.6×	6	560

Countries citing papers authored by Jay Lakshman

Since Specialization

Citations

This map shows the geographic impact of Jay Lakshman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Lakshman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Lakshman more than expected).

Fields of papers citing papers by Jay Lakshman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Lakshman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Lakshman. The network helps show where Jay Lakshman may publish in the future.

Co-authorship network of co-authors of Jay Lakshman

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Lakshman. A scholar is included among the top collaborators of Jay Lakshman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Lakshman. Jay Lakshman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Jumani, Rajiv S., Johanne Blais, Hanns-Christian Tillmann, et al.. (2021). Opportunities and Challenges in Developing a Cryptosporidium Controlled Human Infection Model for Testing Antiparasitic Agents. ACS Infectious Diseases. 7(5). 959–968. 8 indexed citations

2.

Lakshman, Jay, et al.. (2019). OPPORTUNITIES IN DOING THE GREATER GOOD: A BIGGER ROLE FOR PHARMA. INDIAN DRUGS. 56(3). 5–6. 1 indexed citations

3.

LoBrutto, Rosario, et al.. (2010). Investigation of Metformin HCl Lot-to-Lot Variation on Flowability Differences Exhibited during Drug Product Processing. Journal of Pharmaceutical Sciences. 99(12). 5030–5039. 11 indexed citations

4.

Vasanthavada, Madhav, Yanfeng Wang, Thomas Haefele, et al.. (2010). Application of Melt Granulation Technology Using Twin-screw Extruder in Development of High-dose Modified-Release Tablet Formulation. Journal of Pharmaceutical Sciences. 100(5). 1923–1934. 49 indexed citations

5.

Lakshman, Jay, et al.. (2010). Application of Melt Granulation Technology to Enhance Tabletting Properties of Poorly Compactible High-Dose Drugs. Journal of Pharmaceutical Sciences. 100(4). 1553–1565. 84 indexed citations

6.

Lakshman, Jay, et al.. (2008). Application of Melt Extrusion in the Development of a Physically and Chemically Stable High-Energy Amorphous Solid Dispersion of a Poorly Water-Soluble Drug. Molecular Pharmaceutics. 5(6). 994–1002. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact